CAT | Proscar
Proscar – a new effective medicine for treating enlarged prostate
Proscar is a new class medicine inhibiting intracellular enzyme which transforms testosterone into a more active androgenic hormone – dihydrotestosterone. Proscar is not an androgenic hormone agonist.
The growth of prostate gland and further adenoma development depend on testosterone transformation into dihydrotestosterone inside prostate gland just within 24 hours after oral administration of Proscar a considerable reduction of dihydrotestosterone concentration in the system of blood circulation and inside the prostate gland could be observed.
Proscar causes reduction of the enlarged prostate size, facilitates urination and decreases symptoms associated with adenoma. It may require several months of treatment before the clinical manifestations of the disease reduce.
Proscar decreases the risk of all urological interventions by 51% and its use characterized by stable improvement of symptoms. The recommended dose of Proscar is 5 mg once a day independently of food intake. Quick relief is quite possible, but in most cases it takes at least 6 months before appreciable positive results of the therapy could be noticed.
Patients with renal failure do not need special dosage adjustment of Proscar, since pharmacokinetic researches have not revealed any changes in distribution of Proscar in these patients.
The elderly patients do not require any dose adjustment as well, although pharmacokinetic researches showed that excretion rate of Proscar in patients above 70 years old decreases.
What is prostatitis?
Prostatitis is a prostate tissue inflammation, or edema. It is the most common urological diseases in men aged 20-50. It is considered that 30% of men after 30, 40% after 40 and 50 % after 50 years old suffer from prostatitis.
How is prostatitis treated?
On the basis of clinical and laboratory test results a healthcare professional makes up a program for treating prostatitis which includes a whole specter of remedial measures. As a rule the complex treatment program includes antibacterial and antiviral therapy and therapy for toning vessels. The medicines which could be used as vessel toners are Proscar (Finasteride), Eulexin (Flutamide) and Avodart (Dutasteride).
Prostatitis and Potency
Prostate inflammation on its own does not cause impotence. But chronic prostatitis and seminal crest inflammation without timely treatment may lead to lessening of sexual drive, bad erection or premature ejection. Besides other factors prostate also has an impact on vital capacity of spermatozoids and in most cases inflammatory process may cause infertility. One should organize his life in a way so that there were less risk factors which may develop prostatitis. To prevent the diseases mentioned it is recommended to eat healthy, avoid alcohol, spicy and fat food and maintain a stable body weight.